SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
727Sorry but It annoys me that the company is wasting money for no conceivable purpMadharry-10/18/2002
726Good summary of today's events and HGSI's response: biz.yahoo.comSteven Rachbach-10/17/2002
725Interesting to see where the real volume occurred - finance.yahoo.comnigel bates-10/17/2002
724Looks like Sterling wants to close out a short position before the market startsElmer-10/17/2002
723Finally some news! Some thoughts: -- This is real news to me. The hinted at Steven Rachbach-10/8/2002
722Phase 1 results for albutropin -- promising. hgsi.com RESULTS OF PHASE 1 ALBUTSteven Rachbach-10/8/2002
721Vascular Genetics merges with Genstar - Message 17986627 <i>...VGI'snigel bates-9/13/2002
720Coincidentally, infliximab (Remicade) has come up twice for me in the last day aSteven Rachbach-8/8/2002
719Human Genome Sciences Licenses Two Human Antibody Targets To Schering-Plough fornigel bates-7/25/2002
718Let's pray it's the real deal. RegardsElmer-7/17/2002
717A beauty, even tho the 200 MA isn't even on my version: stockcharts.com[g,atom pope-7/17/2002
716Break out? dbc.comElmer-7/17/2002
715I always thought this would be the first genomics derived drug in the clinic. ThElmer-7/16/2002
714Human Genome Sciences Receives a Milestone Payment for Initiation of Clinical Trnigel bates-7/16/2002
713CHICAGO, June 10 /PRNewswire/ -- Mike Chrisman has a knack for using fundamentalRKHIII-6/10/2002
712Signals on genomics drugs coming into the clinic. Given that most of these are tuck-5/21/2002
711Barrons has bit on HGSI this weekend-strong buy stating a investor basically getjohnsto1-5/18/2002
710Short article from Washington Post on HGSI drug trial. washingtonpost.comRKHIII-5/15/2002
709Steve, thanks for your response. Certainly hope they are successful. For now MJ-5/14/2002
708<<does anyone know when the first med. fused with albumin would be determiSteven Rachbach-5/10/2002
707New to this thread but not SI. Invested in HGSI early in its existence and thenMJ-5/9/2002
706Nigel, Your points are well taken. I do believe, however, that most of the druSteven Rachbach-5/1/2002
705<i>most of the genomic drugs in development are being fused to albumin<nigel bates-5/1/2002
704I just finished reviewing the press release and it is evident that most of the gSteven Rachbach-5/1/2002
703ROCKVILLE, Md., April 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (nigel bates-4/30/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News